H. Lundbeck A/S

H. Lundbeck A/S

World Rank (Aug-2026)
3085
Market Cap (Aug-2026)
6.288 Billion USD
World Rank (Jan-05-2024)
3,042
Market Cap (Jan-05-2024)
4.760 Billion USD
World Rank (Jul-30-2023)
3,123
Market Cap (Jul-30-2023)
4.724 Billion USD
World Rank (Jan-07-2022)
3,323
Market Cap (Jan-07-2022)
4.912 Billion USD
World Rank (Jan-01-2021)
2,301
Market Cap (Jan-01-2021)
6.811 Billion USD
Headquarters Country
Denmark
Top Healthcare Companies in Europe
Top Pharmaceutical Companies in Europe
Employee Count
5,399
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
3,911 Million USD
Annual Operating Income in USD
838 Million USD
Annual Net Income in USD
507 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
8,266 Million USD
Total Liabilities in USD
4,312 Million USD
Total Equity in USD
3,955 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Company Website
H. LUNDBECK A/S
Company Profile

Lundbeck is a global pharmaceutical company specialized in brain diseases. Headquarters is in Denmark.

Lundbeck employs approximately 5,800 employees in more than 50 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and California.

Founded Year
1915
Stock Exchange
Nasdaq Nordic
Copenhagen

Share